DE:2BO / Serina Therapeutics, Inc. - Net Long/Short Value

Serina Therapeutics, Inc.
DE ˙ DB
1,46 € ↑0,01 (0,69%)
2026-06-04
AKTIENPREIS
DE:2BO / Serina Therapeutics, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Vanguard Group Inc
BlackRock, Inc.
Morgan Stanley
Vanguard Capital Management Llc
Sio Capital Management, LLC
Avidian Wealth Solutions, LLC
Global Retirement Partners, LLC
State Street Corp
Vanguard Global Advisers, LLC
Wells Fargo & Company/mn
Jane Street Group, Llc
Albion Financial Group /ut
Advisory Services Network, LLC
Piscataqua Savings Bank
Federation des caisses Desjardins du Quebec
Geode Capital Management, Llc
Vanguard Fiduciary Trust Co
Farther Finance Advisors, LLC
Advisor Group Holdings, Inc.
UBS Group AG
Caitong International Asset Management Co., Ltd
Keel Point, LLC
Warren Averett Asset Management, LLC
Rockefeller Capital Management L.P.
Tower Research Capital LLC (TRC)
Bnp Paribas Arbitrage, Sa
Pacifica Partners Inc.
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:SER 1,86 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista